Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle

Background: Aberrant metabolism is recognized as a hallmark of cancer, a pillar necessary for cellular proliferation. Regarding bioenergetics (ATP generation), most cancers display a preference not only toward aerobic glycolysis (“Warburg effect”) and glutaminolysis (mitochondrial substrate level-ph...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tomás Duraj, Josefa Carrión-Navarro, Thomas N. Seyfried, Noemí García-Romero, Angel Ayuso-Sacido
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/1cc69d1a8e794332a08eaed4cf704f72
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1cc69d1a8e794332a08eaed4cf704f72
record_format dspace
spelling oai:doaj.org-article:1cc69d1a8e794332a08eaed4cf704f722021-11-26T04:28:39ZMetabolic therapy and bioenergetic analysis: The missing piece of the puzzle2212-877810.1016/j.molmet.2021.101389https://doaj.org/article/1cc69d1a8e794332a08eaed4cf704f722021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2212877821002404https://doaj.org/toc/2212-8778Background: Aberrant metabolism is recognized as a hallmark of cancer, a pillar necessary for cellular proliferation. Regarding bioenergetics (ATP generation), most cancers display a preference not only toward aerobic glycolysis (“Warburg effect”) and glutaminolysis (mitochondrial substrate level-phosphorylation) but also toward other metabolites such as lactate, pyruvate, and fat-derived sources. These secondary metabolites can assist in proliferation but cannot fully cover ATP demands. Scope of review: The concept of a static metabolic profile is challenged by instances of heterogeneity and flexibility to meet fuel/anaplerotic demands. Although metabolic therapies are a promising tool to improve therapeutic outcomes, either via pharmacological targets or press-pulse interventions, metabolic plasticity is rarely considered. Lack of bioenergetic analysis in vitro and patient-derived models is hindering translational potential. Here, we review the bioenergetics of cancer and propose a simple analysis of major metabolic pathways, encompassing both affordable and advanced techniques. A comprehensive compendium of Seahorse XF bioenergetic measurements is presented for the first time. Major conclusions: Standardization of principal readouts might help researchers to collect a complete metabolic picture of cancer using the most appropriate methods depending on the sample of interest.Tomás DurajJosefa Carrión-NavarroThomas N. SeyfriedNoemí García-RomeroAngel Ayuso-SacidoElsevierarticleCancerEnergy metabolismGlycolysisOxidative phosphorylationResearch designInternal medicineRC31-1245ENMolecular Metabolism, Vol 54, Iss , Pp 101389- (2021)
institution DOAJ
collection DOAJ
language EN
topic Cancer
Energy metabolism
Glycolysis
Oxidative phosphorylation
Research design
Internal medicine
RC31-1245
spellingShingle Cancer
Energy metabolism
Glycolysis
Oxidative phosphorylation
Research design
Internal medicine
RC31-1245
Tomás Duraj
Josefa Carrión-Navarro
Thomas N. Seyfried
Noemí García-Romero
Angel Ayuso-Sacido
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
description Background: Aberrant metabolism is recognized as a hallmark of cancer, a pillar necessary for cellular proliferation. Regarding bioenergetics (ATP generation), most cancers display a preference not only toward aerobic glycolysis (“Warburg effect”) and glutaminolysis (mitochondrial substrate level-phosphorylation) but also toward other metabolites such as lactate, pyruvate, and fat-derived sources. These secondary metabolites can assist in proliferation but cannot fully cover ATP demands. Scope of review: The concept of a static metabolic profile is challenged by instances of heterogeneity and flexibility to meet fuel/anaplerotic demands. Although metabolic therapies are a promising tool to improve therapeutic outcomes, either via pharmacological targets or press-pulse interventions, metabolic plasticity is rarely considered. Lack of bioenergetic analysis in vitro and patient-derived models is hindering translational potential. Here, we review the bioenergetics of cancer and propose a simple analysis of major metabolic pathways, encompassing both affordable and advanced techniques. A comprehensive compendium of Seahorse XF bioenergetic measurements is presented for the first time. Major conclusions: Standardization of principal readouts might help researchers to collect a complete metabolic picture of cancer using the most appropriate methods depending on the sample of interest.
format article
author Tomás Duraj
Josefa Carrión-Navarro
Thomas N. Seyfried
Noemí García-Romero
Angel Ayuso-Sacido
author_facet Tomás Duraj
Josefa Carrión-Navarro
Thomas N. Seyfried
Noemí García-Romero
Angel Ayuso-Sacido
author_sort Tomás Duraj
title Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
title_short Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
title_full Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
title_fullStr Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
title_full_unstemmed Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
title_sort metabolic therapy and bioenergetic analysis: the missing piece of the puzzle
publisher Elsevier
publishDate 2021
url https://doaj.org/article/1cc69d1a8e794332a08eaed4cf704f72
work_keys_str_mv AT tomasduraj metabolictherapyandbioenergeticanalysisthemissingpieceofthepuzzle
AT josefacarrionnavarro metabolictherapyandbioenergeticanalysisthemissingpieceofthepuzzle
AT thomasnseyfried metabolictherapyandbioenergeticanalysisthemissingpieceofthepuzzle
AT noemigarciaromero metabolictherapyandbioenergeticanalysisthemissingpieceofthepuzzle
AT angelayusosacido metabolictherapyandbioenergeticanalysisthemissingpieceofthepuzzle
_version_ 1718409826203074560